Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound) in adults
Branded Medications Only Klinics commitment to quality is evident in its exclusive prescription of branded, FDA-approved medications, ensuring patients receive consistent, verified, and regulatory-compliant treatment
Because some medications also treat Type 2 diabetes, doctors and health-care policy experts continue to watch supply chains to prevent shortages
Prior authorization is often required for GLP-1 medications under Anthem Blue Cross Blue Shield plans in Michigan
These compelling results set Wegovy distinctly apart: To date, there are no approved weight management medications proven to deliver effective weight loss and reducing MACE-3 events, while also being associated with improvements in multiple cardiovascular risk factors
